Good vs. Evil? India rejects Novartis claim on drug improvements
India’s rejection of Novartis’ claim on drug improvements highlights the flexibility of India’s patent laws. Such flexibility stands in sharp contrast to the World Trade
November 13, 2007
1 Comment